Pacira Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Pacira Pharmaceuticals (PCRX) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Pacira Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Pacira Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Pacira Pharmaceuticals by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.5M | 136k | 25.77 |
| 2025-06-30 | $5.1M | 215k | 23.90 |
| 2025-03-31 | $4.3M | 171k | 24.85 |
| 2024-12-31 | $832k | 44k | 18.84 |
| 2024-09-30 | $1.2M | 81k | 15.05 |
| 2023-06-30 | $1.1M | 28k | 40.07 |
| 2023-03-31 | $1.7M | 42k | 40.81 |
| 2022-12-31 | $618k | 16k | 38.61 |
| 2022-03-31 | $502k | 6.6k | 76.36 |
| 2021-12-31 | $511k | 8.5k | 60.22 |
| 2014-03-31 | $417k | 5.4k | 77.22 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management